Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy

被引：0
|
作者：
Elliott, P. [1 ]
Drachman, B. M. [2 ]
Gottlieb, S. S. [3 ]
Hoffman, J. E. [4 ]
Hummel, S. L. [5 ]
Lenihan, D. J. [6 ]
Ebede, B. [7 ]
Gundapaneni, B. [8 ]
Schwartz, J. H. [9 ]
Sultan, M. B. [9 ]
Shah, S. J. [10 ]
机构：
[1] UCL, London, England
[2] Univ Penn, Penn Presbyterian Med Ctr, Hlth Syst, Philadelphia, PA USA
[3] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[4] Univ Miami, Miami, FL USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Pfizer Inc, Collegeville, PA USA
[8] Pfizer Inc, Groton, CT USA
[9] Pfizer Inc, New York, NY USA
[10] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Dept Med, Chicago, IL 60611 USA
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1169
引用
收藏
页码：645 / 645
页数：1
相关论文
共 50 条
  • [41] Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)
    Garcia-pavia, Pablo
    Kristen, Arnt v
    Drachman, Brian
    Carlsson, Martin
    Amass, Leslie
    Angeli, Franca stedile
    Maurer, Mathew S.
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (03) : 525 - 533
  • [42] Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial
    Shah, Sanjiv J.
    Fine, Nowell
    Garcia-Pavia, Pablo
    Klein, Allan L.
    Fernandes, Fabio
    Weissman, Neil J.
    Maurer, Mathew S.
    Boman, Kurt
    Gundapaneni, Balarama
    Sultan, Marla B.
    Elliott, Perry
    JAMA CARDIOLOGY, 2024, 9 (01) : 25 - 34
  • [43] Efficacy of Tafamidis in Patients with Hereditary or Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Results from the ATTR-ACT Trial
    Grogan, M.
    Witteles, R.
    Shah, S. J.
    Schwartz, J. H.
    Gundapaneni, B.
    Patterson, T. A.
    Sultan, M. B.
    Maurer, M. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S204 - S204
  • [44] Cardiopulmonary exercise testing in transthyretin amyloid cardiomyopathy patients: a long-term follow-up study
    Willixhofer, Robin
    Rettl, Rene
    Kronberger, Christina
    Ermolaev, Nikita
    Gregshammer, Bernhard
    Duca, Franz
    Binder, Christina
    Kammerlander, Andreas
    Alasti, Farideh
    Kastner, Johannes
    Bonderman, Diana
    Bergler-Klein, Jutta
    Agostoni, Piergiuseppe
    Badr Eslam, Roza
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2024, 25 (09) : 704 - 712
  • [45] Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing Surveillance
    Ishii, Tomonori
    Hirano, Yoko
    Matsumoto, Noriko
    Takata, Ami
    Sekijima, Yoshiki
    Ueda, Mitsuharu
    Ando, Yukio
    CLINICAL THERAPEUTICS, 2020, 42 (09) : 1728 - +
  • [46] Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years
    Barroso, Fabio A.
    Judge, Daniel P.
    Ebede, Ben
    Li, Huihua
    Stewart, Michelle
    Amass, Leslie
    Sultan, Marla B.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 (03): : 194 - 204
  • [47] AN INTERIM ANALYSIS OF LONG-TERM EXTENSION TRIALS OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    van Vollenhoven, R. F.
    Smolen, J. S.
    Tony, H. P.
    Codding, C.
    Keystone, E. C.
    Woodworth, T.
    Alecock, E.
    Alten, R.
    RHEUMATOLOGY, 2009, 48 : I86 - I87
  • [48] Effects of tafamidis on heart failure hospitalization: the tale of the dog that did not bark. Letter regarding the article 'Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms'
    Aimo, Alberto
    Vergaro, Giuseppe
    Emdin, Michele
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (02) : 526 - 526
  • [49] Long term effects of tafamidis treatment on transthyretin familial amyloid polyneuropathy (TTR-FAP): interim results from the Fx1A-303 study
    Coelho, T.
    Conceicao, I. M.
    Barroso, F.
    Waddington-Cruz, M.
    Schmidt, H. H. -J.
    Rosas, G.
    Mandel, F. S.
    Stewart, M.
    Huertas, P.
    Karayal, O. N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 81 - 81
  • [50] Long term effects of tafamidis treatment on transthyretin familial amyloid polyneuropathy (TTR-FAP): interim results from the Fx1A-303 study
    Coelho, T.
    Conceicao, I. M.
    Barroso, F.
    Waddington-Cruz, M.
    Schmidt, H. H. -J.
    Rosas, G.
    Mandel, F. S.
    Stewart, M.
    Huertas, P.
    Karayal, O. N.
    JOURNAL OF NEUROLOGY, 2014, 261 : S59 - S60
12345